Lepromatous Leprosy: Clinical Trials

3 trials for Lepromatous Leprosy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting. 1 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 41Completed 1

Follow Lepromatous Leprosy: new trials by email Literature Review of Lepromatous Leprosy trials Research Report on Lepromatous Leprosy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Hansen's Disease in Costa Rica (2018-2025)
Leprosy, Hansen's Disease
Not yet recruitingCaja Costarricense de Seguro Social1302026-05-012026-03-09
Effect of Additional Clofazimine on Erythema Nodosum Leprosum (ENL) Reactions in Leprosy
Clofazimine, Placebo - Borderline Lepromatous Leprosy, Lepromatous Leprosy
Phase 4CompletedPaul Saunderson1002010-08-012015-06-04
Microcirculatory Impairment in Patients With Leprosy
acetylcholine Iontophoresis, sodium nitroprusside Iontophoresis - Lepromatous Leprosy
Not applicableCompletedCurt Treu202006-03-012014-03-12

Narrower conditions

Leprosy (3)  ·  Leprosy, Lepromatous (3)  ·  Leprosy, Multibacillary (1)  ·  Neurologic Manifestations (1)

Broader conditions

Actinomycetales Infections (3)  ·  Bacterial Infections (3)  ·  Bacterial Infections and Mycoses (3)  ·  Gram-Positive Bacterial Infections (3)  ·  Infections (3)  ·  Mycobacterium Infections (3)  ·  Mycobacterium Infections, Nontuberculous (3)  ·  Leprosy, Multibacillary (2)  ·  Nervous System Diseases (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Clofazimine (1)  ·  Vitamins (1)

Sponsors

Caja Costarricense de Seguro Social (1)  ·  Curt Treu (1)  ·  Paul Saunderson (1)

Countries

Costa Rica (1)  ·  Philippines (1)

Top investigators

Eliete Bouskela, PhD (1)  ·  Marivic Balagon, MD (1)